Clinical Trials Directory

Trials / Terminated

TerminatedNCT00858559

Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Biotronik SE & Co. KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with implantable cardioverter defibrillators (ICDs) should undergo regular device follow-ups every 3 months, to verify proper ICD function. However, many follow-ups are uneventful, revealing no relevant changes related to the implanted device and in the patient's diagnostic and therapeutic status. For time and economic reasons, longer follow-up intervals are frequently used although they are not according to recommendations. This may increase the delay in detection of relevant changes in the disease and in deviations from optimal ICD therapy in the individual patients. In the newest ICDs, the essential parameters reflecting safety and appropriateness of ICD therapy (threshold, impedance, intracardiac electrogram, etc.) are transmitted via Home Monitoring on a daily basis, to an internet platform accessible by the attending physician. In the present study, the investigators evaluate safety and efficacy of 12-month follow-up intervals in ICDs with Home Monitoring capability, as compared with conventional 3-month follow-up scheme.

Conditions

Interventions

TypeNameDescription
DEVICEImplantable cardioverter defibrillator with Home Monitoring functionImplantable cardioverter defibrillators can send data from its diagnostic and therapy memory via wireless Home Monitoring on a daily basis to an internet based platform, securely accessed by the attending physician
DEVICEStandard implantable cardioverter defibrillatorImplantable cardioverter defibrillators used as standard devices without Home Monitoring

Timeline

Start date
2009-03-01
Primary completion
2011-09-01
Completion
2011-12-01
First posted
2009-03-10
Last updated
2017-08-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00858559. Inclusion in this directory is not an endorsement.